Blogs about Biotechnology, Pharmaceutical and Healthcare

13:12 EDT 27th August 2014 | BioPortfolio

Read the latest opinions - blogs from pharmaceutical and life science industry experts.

Showing News Articles 1–25 of 56,000+

Wednesday 27th August 2014

Doubling Down on ACOs and Health Information Networks

By JAAN SIDOROV, MD Want to achieve effective health care, reduced costs, increased quality, population health, widespread prevention and seamless health information access? It’s easy, says this article in Population Health Management: mix one...

Looking Beyond Medicare’s Nursing Home Ratings: What To Know Before Picking a Facility

This week, The New York Times published an investigative report by Katie Thomas on Medicare’s five-star rating system for nursing homes.  Among its findings: Medicare’s Nursing Home Compare tool relies largely on self-reported data by the facili...

Japan May Provide West African Countries With Unapproved Ebola Treatment

The Japanese government is ready to provide Ebola afflicted countries an experimental drug that has not yet been approved by the WHO On Monday the 27th of August, Japan’s Chief Cabinet Secretary Yoshihide Suga announced that the country is willing to donate a flu drug called Favipiravir to aid the Ebola crisis in west Africa. […]

AirStrip Raises $25M to Expand into Home Health, Foreign Markets

Has a CDC Whistleblower Really Come forward? #CDCwhistleblower

Antivaccine groups claim CDC scientist has confessed to a CDC cover up and fraud regarding a vaccine-autism link, comparing CDC to Stalin, Pol Pot and Hitler Once again we find the world of social media ablaze with claims that ‘proof’ of a link between early MMR vaccination and autism has been uncovered. This time, through a […]

San Diego Venture Group Names Mike Krenn as New President

University of California, San Diego (UCSD) Scientist Finds Clearer Obesity, Diabetes Connection

StemCutis Attracts Stem Cell Entrepreneur As President And CEO And Noted Dermatologist As Director

Update: BioSpecifics Announces Positive XIAFLEX Data For Cellulite

By Andy Batts:BioSpecifics Technologies (NASDAQ:BSTC) recently announced positive, statistically significant results from a randomized, double-blind Phase 2a study of collagenase clostridium histolyticum or CCH (known as XIAFLEX in the in the US and XIAPEX in the EU) for the potential treatment of edematous fibrosclerotic panniculopathy, commonly called cellulite. Three doses of CCH were administe...

Houston’s Bellicum Nets $55M to Boost Trials for Cancer Treatment

Houston biotech firm Bellicum Pharmaceuticals announced Wednesday it has raised $55 million in a Series C financing. Bellicum said 11 biotech and public mutual funds participated in the round, including RA Capital Management, Perceptive Advisors, Jen...

Update: Intuitive Surgical's Firefly For Xi Has Been Approved By The FDA

By Andy Batts:Intuitive Surgical (NASDAQ:ISRG) has received FDA approval for its Fluorescence Imaging Vision System, called Firefly, as an optional feature for its robotic surgical system da Vinci Xi. Upon approval, the company will start shipping Firefly installed in the da Vinci Xi systems. The company launched da Vinci Xi in April 2014, followed by its FDA clearance.Firefly will help surgeons l...

GenMark Diagnostics Hoping To Make Its Mark In Clinical MDx

By Stephen Simpson, CFA:Molecular diagnostics is still a relatively new opportunity in the clinical diagnostics space - about $4 billion/year if Roche's (OTCQX:RHHBY) estimates of its market share are accurate. It remains a good growth opportunity, though, as molecular diagnostic technologies can in many cases offer faster and more accurate results for healthcare providers. GenMark Diagnostics (NA...

CDC Responds to #CDCwhistleblower Claims

CDC Statement Regarding 2004 Pediatrics Article, “Age at First Measles-Mumps-Rubella Vaccination in Children With Autism and School-matched Control Subjects: A Population-Based Study in Metropolitan Atlanta” CDC shares with parents and others great concern about the number of children with autism spectrum disorder. CDC is committed to continuing to provide essential data on autism, sea...

Bio-Reference Laboratories (BRLI) Q3 2014 Results - Earnings Call Webcast

By SA Transcripts:The following audio is from a conference call that will begin on August 27, 2014 at 10:30 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion. Listen nowComplete Story »

22nd Century Group: A Lot Of Smoke, Not Enough Fire

By The GeoTeam:22nd Century Group, Inc. (NYSEMKT:XXII) became public on January 25th, 2011 through a reverse merger with shell company Touchstone Mining Limited (source 21).We believe investors will come to the same conclusion that we have-XXII is just rekindling a story that already has failed in the past. From 2011 to the beginning of 2014, the stock was trading well below where it's trading tod...

Why Amgen Stock Is A Long-Term Investment Opportunity

By Arie Goren:Amgen Inc. (NASDAQ:AMGN) will continue to benefit from the growing demand for its products, and from its top-quality pipeline that should sustain long-term growth. Amgen's restructuring plan will provide savings and will enable the company to focus on growth areas. AMGN's stock has surged strongly since the start of 2012. In fact, its relative strength index (RSI) technical indicator...

KevinMD's Take, August 27, 2014

By Kevin, M.D. A recent study from JAMA found, unsurprisingly, that older patients are getting screened for cancer way too often. From Vox: Between a third and half of older patients with a limited life expectancy are undergoing routine cancer scre...

Nonprofit Hospitals' Profits Drop

Nonprofit hospitals' income declined for a second straight year in 2013 and their median rate of revenue growth fell to an all-time low, according to a new report from credit firm Moody's Investors Service.

Gilead Sciences: Due For More Short Squeezing?

By Jason Russ:Short sellers of Gilead Sciences (NASDAQ:GILD) must be starting to sweat a bit as the stock continues its impressive trajectory:GILD data by YChartsRight along with the rising share price, the shorts have been piling on:GILD Short Interest data by YChartsHowever, the short interest figures just came out for the first half of August and they in fact show that about 8 million shares we...

MACMILLAN CANCER SUPPORT RESPONDS TO THE LATEST CANCER SURVIVAL FIGURES

Today [Tuesday] Public Health England’s National Cancer Intelligence Network (NCIN) published new one-year cancer survival data for England1. Mike Hobday, Director of Policy and Research at Macmillan Cancer Support, says: “Whilst it’s encouraging to see that overall survival rates for some of the most common cancers in England are improving, we know that we still [...]

Sanofi Looks For Clarity From Dengue Vaccine Trials

Sanofi has been arduously working to develop a dengue vaccine for 20 long years. Now in the final stages of development with its first prophylactic candidate, the French drug maker is hoping for clarity on its effectiveness against dengue virus serot...

This is what lifelong learning in medicine should look like

He left a little early to stop by the cath lab to see his patient before her procedure.  Cordial “hellos,” “good mornings,” and “any last questions?” were mentioned before she signed her consent.  The team was working feverishly to prepare her for her procedure.  “Have you met the anesthesiologist yet?” was next, and almost on […]

Scanalytics, Stemina Among Wisconsin Innovation Awards Winners

Fast-growing vegetables that can be delivered by bicycle, a traveling truck providing free legal advice, and a breath-analyzing device for rapidly detecting infections were among the 10 winners of the inaugural Wisconsin Innovation Awards held Tuesda...

On the first day of school, a letter to my child’s teacher

I don’t know you and you don’t know me, but today you become one of the most important people in my life. You are the one. The one who I’ve entrusted to take care of my girl in my absence. The one who I’ve tasked with teaching her things that I cannot. The one who will […]

The new Frank N. Foode™!

Here’s a short update that I’m sure everyone will be interested to hear about. After several redesigns and adjustments, I’m really pleased to announce that the design for the new Frank N. Foode plushie that many of you have been wai...


Search BioPortfolio:
Advertisement
Advertisement